🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 3 (extension) clinical trial to examine the efficacy of IPI-145 (du...
Status
Completed
Location
Multiple Locations
Start Date
2013-12
Trial ID
NCT02049515
Treatments Being Tested
The purpose of this study is to examine the effects of multi-dose regimens ...
Status
Completed
Location
Investigational Site
Start Date
2012-07
Trial ID
NCT01653756
Treatments Being Tested
To evaluate the safety, pharmacokinetics, and pharmacodynamics of Duvelisib...
Status
Terminated
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT02292225
Treatments Being Tested
Indolent T/NK-cell lymphomas are a heterogeneous group of lymphoproliferati...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2024-08-10
Trial ID
NCT06530550
Treatments Being Tested
This research study is evaluating a new drug called IPI-145 in combination ...
Status
Active Not Recruiting
Location
Beth Isreal Deaconess Medical Center
Start Date
2014-06-27
Trial ID
NCT02158091
Treatments Being Tested
Protocol YY-20394-003 is a phase I single arm, open label study. The primar...
Status
Unknown
Location
Shanghai East Hospital
Start Date
2019-08
Trial ID
NCT04049929
Treatments Being Tested
This study was designed to assess the safety and preliminary efficacy of du...
Status
Terminated
Location
UPMC Hillman Cancer Center
Start Date
2020-06-01
Trial ID
NCT04193293
Treatments Being Tested
This was a Phase 2 clinical trial to evaluate the safety and efficacy of du...
Status
Completed
Location
Multiple Locations
Start Date
2013-06-17
Trial ID
NCT01882803
Treatments Being Tested
A Phase 2, single arm, open label clinical study to evaluate the efficacy, ...
Status
Unknown
Location
Multiple Locations
Start Date
2020-12-30
Trial ID
NCT04379167
Treatments Being Tested
A Phase 3 clinical trial to examine the efficacy of duvelisib monotherapy v...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT02004522
Treatments Being Tested